US1374041093
US1374041093
Candel Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 48.177.000 | 33.371.000 | 44.4% | |
| Operating Income | -48.177.000 | -33.371.000 | 44.4% |
| Pretax Income | -38.182.000 | -55.177.000 | 30.8% |
| Net Income Common Stockholders | -38.182.000 | -55.177.000 | 30.8% |
| -- | -- | -- | |
| -- | -- | -- |